Hostname: page-component-cd9895bd7-mkpzs Total loading time: 0 Render date: 2024-12-26T15:16:20.008Z Has data issue: false hasContentIssue false
  • English
  • Français

Effect of newborn screening for critical CHD on healthcare utilisation

Published online by Cambridge University Press:  02 July 2020

Rie Sakai-Bizmark Open the ORCID record for Rie Sakai-Bizmark [Opens in a new window] ,
Hiraku Kumamaru ,
Eliza J. Webber ,
Dennys Estevez ,
Laurie A. Mena ,
Emily H. Marr  and
Ruey-Kang R. Chang
Rie Sakai-Bizmark*
Affiliation:
Department of Pediatrics, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA, USA Department of Pediatrics, Harbor-UCLA Medical Center and the David Geffen School of Medicine, University of California at Los Angeles, Torrance, CA, USA
Hiraku Kumamaru
Affiliation:
Department of Healthcare Quality Assessment, The University of Tokyo School of Medicine, Tokyo, Japan
Eliza J. Webber
Affiliation:
Department of Pediatrics, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA, USA
Dennys Estevez
Affiliation:
Department of Pediatrics, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA, USA
Laurie A. Mena
Affiliation:
Department of Pediatrics, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA, USA
Emily H. Marr
Affiliation:
Department of Pediatrics, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA, USA
Ruey-Kang R. Chang
Affiliation:
Department of Pediatrics, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA, USA Department of Pediatrics, Harbor-UCLA Medical Center and the David Geffen School of Medicine, University of California at Los Angeles, Torrance, CA, USA
*
Author for correspondence: Rie Sakai-Bizmark, MD, PhD, MPH, Assistant Professor, Department of Pediatrics, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, David Geffen School of Medicine at UCLA, 1124 West Carson Street, Torrance, CA90502, USA. Tel: +1 (310) 222 3699; Fax: +1 (310) 222 4006. E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

To evaluate the impact of state-mandated policies for pulse oximetry screening on healthcare utilisation, with a focus on use of echocardiograms.

Data sources/study setting:

Healthcare Cost and Utilisation Project, Statewide Inpatient Databases from 2008 to 2014 from six states.

Methods:

We defined pre- and post-mandate cohorts based on dates when pulse oximetry became mandated in each state. Linear segmented regression models for interrupted time series assessed associations between implementation of the screening and changes in rate of newborns with Critical CHD-negative echocardiogram results. We also evaluated the changes in rate of newborns who underwent echocardiogram but were not diagnosed with any health issues that could cause hypoxemia.

Results:

We identified 5967 critical CHD-negative echocardiograms (2847 and 3120 in the pre- and post-mandate periods, respectively). Our models detected a statistically significant increasing trend in rate of critical CHD-negative echocardiograms in the pre-mandate period (Incidence Rate Ratio: 1.08, p = 0.02), but did not detect any statistical differences in changes between pre- and post-mandate periods (Incidence Rate Ratio: 0.93, p = 0.14). Among non-Whites, an increasing trend of Critical CHD-negative echocardiogram during the pre-mandate period was detected (Incidence Rate Ratio 1.12, p < 0.01) and was attenuated during the post-mandate period (Incidence Rate Ratio 0.89, p = 0.02). Similar results were observed in the sensitivity analyses among both Whites and non-Whites.

Conclusions:

Results suggest that mandatory state screening policies are associated with reductions in false-positive screening rates for hypoxemic conditions, with reductions primarily attributed to trends among non-Whites.

Keywords

Critical CHDCHDhypoxemiamandated policynewborn
Type
Original Article
Information
Cardiology in the Young , Volume 30 , Issue 8 , August 2020 , pp. 1157 - 1164
Copyright
© The Author(s), 2020. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Centers for Disease Control and Prevention. Pulse Oximetry Screening for Critical Congenital Heart Defects, 2012. Retrieved March 28, 2017, from https://www.cdc.gov/features/congenitalheartdefects/Google Scholar
Hoffman, JIE, Kaplan, S.The incidence of congenital heart disease. J Am Coll Cardiol 2002; 39: 1890–1900.CrossRefGoogle ScholarPubMed
Peterson, C, Dawson, A, Grosse, SD, et al.Hospitalizations, costs, and mortality among infants with critical congenital heart disease: how important is timely detection? Birth Defects Res Part a-Clin Mol Teratol 2013; 97: 664–672.CrossRefGoogle ScholarPubMed
Secretary’s Advisory Committee on Heritable Disorders in Newborns and Children. HHS Secretary Adopts Recommendation to ad Critical Congenital Heart Disease to the Recommended Uniform Screening Panel. September 21, 2011. Retrieved December 17, 2015, from http://www.hrsa.gov/advisorycommittees/mchbadvisory/heritabledisorders/recommendations/correspondence/cyanoticheartsecre09212011.pdfGoogle Scholar
Hayeems, RZ, Miller, FA, Vermeulen, M, et al.False-positive newborn screening for cystic fibrosis and health care use. Pediatrics 2017; 140: e20170604.CrossRefGoogle ScholarPubMed
Karaceper, MD, Chakraborty, P, Coyle, D, et al.The health system impact of false positive newborn screening results for medium-chain acyl-CoA dehydrogenase deficiency: a cohort study. Orphanet J Rare Dis 2016; 11: 12.CrossRefGoogle ScholarPubMed
Hewlett, J, Waisbren, SE.A review of the psychosocial effects of false-positive results on parents and current communication practices in newborn screening. J Inherit Metab Dis 2006; 29: 677–682.CrossRefGoogle ScholarPubMed
Rueegg, CS, Barben, J, Hafen, GM, et al.Newborn screening for cystic fibrosis – the parent perspective. J Cystic Fibrosis 2016; 15: 443–451.CrossRefGoogle ScholarPubMed
Kerruish, NJ, Healey, DM, Gray, AR.Psychosocial effects in parents and children 12 years after newborn genetic screening for type 1 diabetes. Eur J Hum Genet 2017; 25: 397–403.CrossRefGoogle ScholarPubMed
Granelli, AD, Wennergren, M, Sandberg, K, et al.Impact of pulse oximetry screening on the detection of duct dependent congenital heart disease: a Swedish prospective screening study in 39 821 newborns. Br Med J 2009; 338: a3037.CrossRefGoogle Scholar
Plana, MN, Zamora, J, Suresh, G, Fernandez-Pineda, L, Thangaratinam, S, Ewer, AK.Pulse oximetry screening for critical congenital heart defects. Cochrane Database Syst Rev 2018; 3: CD011912.Google ScholarPubMed
Healthcare Cost and Utilization Project (HCUP). HCUP Partners, 2016. Retrieved May 2, 2018, from https://www.hcup-us.ahrq.gov/partners.jspGoogle Scholar
Diller, CL, Kelleman, MS, Kupke, KG, Quary, SC, Kochilas, LK, Oster, ME.A modified algorithm for critical congenital heart disease screening using pulse oximetry. Pediatrics 2018; 141: e20174065.CrossRefGoogle ScholarPubMed
Centers for Disease Control and Prevention. CDC Wide-ranging Online Data for Epidemiologic Research (CDC WONDER), 2018. Retrieved May 23, 2018, from https://wonder.cdc.gov/Google Scholar
Abouk, R, Grosse, SD, Ailes, EC, Oster, ME.Association of US state implementation of newborn screening policies for critical congenital heart disease with early infant cardiac deaths. Jama-J Am Med Assoc 2017; 318: 2111–2118.10.1001/jama.2017.17627CrossRefGoogle ScholarPubMed
Klausner, R, Shapiro, ED, Elder, RW, Colson, E, Loyal, J.Evaluation of a screening program to detect critical congenital heart defects in newborns. Hosp Pediatr 2017; 7: 214–218.CrossRefGoogle ScholarPubMed
Garg, LF, Braun, KV, Knapp, MM, et al.Results from the New Jersey statewide critical congenital heart defects screening program. Pediatrics 2013; 132: E314–E323.CrossRefGoogle ScholarPubMed
Knowles, R, Griebsch, I, Dezateux, C, Brown, J, Bull, C, Wren, C.Newborn screening for congenital heart defects: a systematic review and cost-effectiveness analysis. Health Technol Assess 2005; 9: 1.CrossRefGoogle ScholarPubMed
Roberts, TE, Barton, PM, Auguste, PE, Middleton, LJ, Furmston, AT, Ewer, AK.Pulse oximetry as a screening test for congenital heart defects in newborn infants: a cost-effectiveness analysis. Arch Dis Child 2012; 97: 221–226.CrossRefGoogle ScholarPubMed
Cahan, C, Decker, MJ, Hoekje, PL, Strohl, KP. Agreement between noninvasive oximetric values for oxygen-saturation. Chest 1990; 97: 814–819.CrossRefGoogle ScholarPubMed
Jubran, A, Tobin, MJ.Reliability of pulse oximetry in titrating supplemental oxygen-therapy in ventilator-dependent patients. Chest 1990; 97: 1420–1425.CrossRefGoogle ScholarPubMed
Zeballos, RJ, Weisman, IM.Reliability of noninvasive oximetry in black subjects during exercise and hypoxia. Am Rev Respir Dis 1991; 144: 1240–1244.CrossRefGoogle ScholarPubMed
Bothma, PA, Joynt, GM, Lipman, J, et al.Accuracy of pulse oximetry in pigmented patients. S Afr Med J 1996; 86: 594–596.Google ScholarPubMed
Adler, JN, Hughes, LA, Vivilecchia, R, Camargo, CA.Effect of skin pigmentation on pulse oximetry accuracy in the emergency department. Acad Emerg Med 1998; 5: 965–970.CrossRefGoogle ScholarPubMed
Feiner, JR, Severinghaus, JW, Bickler, PE.Dark skin decreases the accuracy of pulse oximeters at low oxygen saturation: the effects of oximeter probe type and gender. Anesth Analg 2007; 105: S18–S23.CrossRefGoogle ScholarPubMed
Gavin, NI, Adams, EK, Hartmann, KE, Benedict, MB, Chireau, M.Racial and ethnic disparities in the use of pregnancy-related health care among medicaid pregnant women. Matern Child Health J 2004; 8: 113–126.CrossRefGoogle ScholarPubMed
DiBardino, DJ, Pasquali, SK, Hirsch, JC, et al.Effect of sex and race on outcome in patients undergoing congenital heart surgery: an analysis of the society of thoracic surgeons congenital heart surgery database. Ann Thorac Surg 2012; 94: 2054–2060.CrossRefGoogle Scholar
Collins, JW, Soskolne, G, Rankin, KM, Ibrahim, A, Matoba, N.African-American: white disparity in infant mortality due to congenital heart disease. J Pediatr 2017; 181: 131–136.CrossRefGoogle ScholarPubMed
Nembhard, WN, Salemi, JL, Ethen, MK, Fixler, DE, DiMaggio, A, Canfield, MA.Racial/ethnic disparities in risk of early childhood mortality among children with congenital heart defects. Pediatrics 2011; 127: E1128–E1138.CrossRefGoogle ScholarPubMed
Dismuke, CE.Underreporting of computed tomography and magnetic resonance imaging procedures in inpatient claims data. Med Care 2005; 43: 713–717.CrossRefGoogle ScholarPubMed
Quan, H, Parsons, GA, Ghali, WA.Validity of procedure codes in international classification of diseases, 9th revision, clinical modification administrative data. Med Care 2004; 42: 801–809.CrossRefGoogle ScholarPubMed
Haut, ER, Pronovost, PJ, Schneider, EB.Limitations of administrative databases. J Am Med Assoc 2012; 307: 2589–2589.CrossRefGoogle ScholarPubMed
Beissel, DJ, Goetz, EM, Hokanson, JS.Pulse oximetry screening in wisconsin. Congenit Heart Dis 2012; 7: 460–465.CrossRefGoogle ScholarPubMed
Clark, P, Pringle, J, Simeone, RM, et al.Assessment of current practices and feasibility of routine screening for critical congenital heart defects – georgia, 2012. Mmwr-Morb Mortal Wkly Rep 2013; 62: 288–291.Google Scholar
Kemper, AR, Mahle, WT, Martin, GR, et al.Strategies for implementing screening for critical congenital heart disease. Pediatrics 2011; 128: e1259–e1267.CrossRefGoogle ScholarPubMed
John, C, Phillips, J, Hamilton, C, Lastliger, A.Implementing universal pulse oximetry screening in west virginia: findings from year one. W V Med J 2016; 112: 42–46.Google ScholarPubMed
Supplementary material: File

Sakai-Bizmark et al. Supplementary Materials

Sakai-Bizmark et al. Supplementary Materials

Download Sakai-Bizmark et al. Supplementary Materials(File)
File 1.8 MB